JIM
PBYI icon

Jupiter Investment Management’s Puma Biotechnology PBYI Stock Holding History

Jupiter Investment Management’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$1.88M Buy
+179,999
New +$1.86M 0.03% 252

Other funds holding PBYI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Jupiter Investment Management's PBYI Position: Q2 2020 in Review

Jupiter Investment Management opened a new position in Puma Biotechnology (PBYI) in Q2 2020: 179,999 shares worth $1.88M. The stake represents 0.03% of the portfolio and ranks #252 among its holdings.

128 funds tracked by Wall St. Rank hold PBYI as of Q2 2020.

  • Jupiter Investment Management held 179,999 shares of Puma Biotechnology worth $1.88M as of Q2 2020.
  • Puma Biotechnology was a new Jupiter Investment Management position in Q2 2020.
  • Puma Biotechnology made up 0.03% of Jupiter Investment Management's portfolio in Q2 2020, its #252 holding.
  • 128 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2020.

Based on Jupiter Investment Management's 13F filing for Q2 2020, filed 13 Jul 2020.